The coronary guide catheter, as a core instrument in the field of cardiovascular interventional diagnosis and treatment, is a key carrier for achieving accurate diagnosis of coronary artery lesions and an important tool for clinically implementing the "gold standard" diagnosis of coronary heart disease. This device is precisely delivered to the coronary artery opening via peripheral vascular pathways such as the radial and femoral arteries. With its optimized end-hole or side-hole design and smooth material, it can evenly deliver contrast agents, clearly visualizing the entire vascular tree under X-ray fluoroscopy.
This helps physicians intuitively determine the location, extent, and severity of lesions such as vascular stenosis, occlusion, and malformations, providing core evidence for screening and diagnosis of coronary heart disease, pre-operative planning, precise intra-operative guidance, and post-operative efficacy evaluation. Its segmented variable stiffness design and reinforced braided structure combine excellent pushability, shape memory, and biocompatibility. It can flexibly navigate through tortuous vessels, ensuring safe and convenient operation, while also improving the clarity of angiographic images and diagnostic accuracy. This lays a solid foundation for subsequent interventional treatments such as stent implantation and balloon angioplasty, and is widely used in cardiovascular departments of medical institutions at all levels, building a strong diagnostic and treatment bridge for protecting patients' heart health.
Zhejiang Barty Medical Technology Co.,Ltd Website:www.vascularbarty.com
Established in the year of 2015, Barty was committed to the R&D of vascular intervention including cardiovascular and peripheral system. Our product line includes: DCB Catheter, introducer sheath, angiography catheter, guide catheter,Hp ptca& pta balloon catheter as well as DES,BMS etc. By far, We have got CE certification, ISO13485, free sale certification, dozens of patents on our products, and started to promoting to the domestic and overseas markets.
With the building area of 5,000 square meters, our factory is a Million level purification (local hundred level) clean workshop in line with the "GMP" requirements, in which equipped with our professional facilities and workers. Most of them are in the field for decades under the directions of our best senior engineer.
PTCA balloon catheter, Introducer sheath set, angiography catheter, guide catheter, balloon catheter for coronary and peripheral systems and other vascular interventional devices.Our products are applicable in the vascular intervention of coronary and peripheral system .
Mapuche Medical
Possesses strong technical expertise in the coronary guide catheter sub-market. The company is headquartered in the Pingshan Biomedical Innovation Industrial Park in Shenzhen, with over 10,000㎡ of production facilities and more than 3,000㎡ of cleanroom space. It is equipped with high-precision automated production lines and is ISO13485 certified. Mapuche Medical has established four major product lines: coronary, peripheral, neurological, and urological. More than 10 products, including coronary microcatheters and guide catheters, have obtained domestic registration certificates, and 5 products have obtained EU CE certificates. Technologically, the company has overcome key process bottlenecks such as precision extrusion and hydrophilic coating.
Revita Medical
An innovative enterprise focusing on the R&D and manufacturing of coronary interventional medical devices. The company's core team members come from internationally renowned cardiovascular medical device companies and possess extensive R&D, production, and market experience. It has a Class 10,000 cleanroom, physical and chemical testing laboratories, and sterile testing laboratories, equipped with advanced domestic medical catheter and braiding production lines. Currently, its R&D and mass-produced products include disposable guide catheters, guidewires, and catheter sheath sets – core consumables for coronary intervention. The company focuses on collaborating with well-known industry experts, precisely matching clinical needs, and plans to add five new interventional products in the cardiovascular field within five years, gradually improving its product matrix and steadily expanding its presence in niche markets.
Dimark Medical
A local enterprise deeply rooted in the field of cardiovascular interventional consumables, specializing in the R&D and industrialization of coronary guide catheters and balloon catheters. With its solid production processes and compliance management, the company has successfully been selected for the Shenzhen coronary guide catheter procurement list. Its products focus on the grassroots medical market, gaining recognition from medical institutions for their reliable performance and moderate prices. Dimark Medical emphasizes localized product adaptation, optimizing product design based on the vascular anatomical characteristics of domestic patients. It aligns key indicators such as pushability and flexibility with actual clinical needs, while strictly controlling production processes to ensure product quality stability, gradually establishing brand awareness in regional markets.
Beixin Technology
While its core strength lies in precision diagnostic and treatment equipment such as intravascular ultrasound (IVUS) systems, it also has a deep presence in the field of coronary extension catheters (core consumables for guide catheters), making it a niche supplier with both innovative capabilities and technological barriers. Founded in 2015, the company is a national-level specialized and innovative "little giant" enterprise, boasting four core technology platforms and over 170 authorized patents both domestically and internationally. Its independently developed TrueExtensio® series extension catheters, utilizing an innovative "self-coaxial" design, significantly improve the support and device passage capabilities of guiding catheters in complex coronary artery lesions. The product has received multiple Class III medical device registration certificates, and its performance is comparable to international standards. It primarily serves complex PCI surgical procedures in tertiary hospitals, filling a gap in the domestic high-end extension catheter market.